info@seagull-health.com

SeagullHealth

语言:

Homepage

Drugs

Opicapone(Ongentys)

Names

奥匹卡朋,阿片哌酮

Indicatons

Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in Parkinson's disease.

Price:

Manufacturer:

BIAL

Dosage form:

CAPSULE

Validity period:

24 months

Reminder: The outer packaging is for reference only, please purchase and use under the guidance of a pharmacist. For read by medical and pharmaceutical professionals only.

Ongentys(Opicapone) Instructions:Uses,Dosage, Side Effects

ONGENTYS is an orally administered medication belonging to the class of peripheral, selective, and reversible catechol-O-methyltransferase (COMT) inhibitors. Its active pharmaceutical ingredient is opicapone. The product is formulated as hard gelatin capsules, available in two dosage strengths, and functions by modulating the metabolism of levodopa, thereby enhancing its therapeutic effects in the management of Parkinson's disease.

Generic name

Opicapone(Ongentys)

English name

Opicapone

Alternative Names

奥匹卡朋,阿片哌酮

Drug prices

Indications

ONGENTYS® is indicated as an adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing "off" episodes.

Therapeutic Target

Peripheral, selective, and reversible Catechol-O-methyltransferase (COMT) enzyme.

Active Ingredients

Opicapone

Dosage Form

CAPSULE

Specifications

50mg * 90 capsules/box

Dosage and Administration

50 mg orally once daily at bedtime.

Related Columns

Recommended articles

Side Effects of Opicapone (Ongentys)

Opicapone (Ongentys) is a selective, reversible peripheral catechol-O-methyltransferase (COMT) inhibitor. It is used as an adjunctive therapy to levodopa/carbidopa to improve "off" period sy...

What Are the Precautions for Using Opicapone (Ongentys)?

Opicapone (Ongentys) is a novel peripherally selective and reversible catechol-O-methyltransferase (COMT) inhibitor that has been approved by the U.S. Food and Drug Administration (FDA) as an adjuncti...

Dosage and Administration, Recommended Dose of Opicapone (Ongentys)

Opicapone (Ongentys) is a selective, reversible peripheral catechol-O-methyltransferase (COMT) inhibitor. It is used as an adjunctive therapy to levodopa/carbidopa for the management of "off"...

What Are the Indications for Opicapone (Ongentys)?

Opicapone (Ongentys) is a novel, peripherally selective and reversible catechol-O-methyltransferase (COMT) inhibitor. It was approved for marketing by the U.S. Food and Drug Administration (FDA) in 20...

What Are the Purchase Channels for Opicapone (Ongentys)?

Opicapone (Ongentys) is a selective and reversible peripheral catechol-O-methyltransferase (COMT) inhibitor. It was first approved in the United States in 2020 and is mainly used as an adjunctive ther...

Departments